Clinical information

Indications for use

Please be aware that our products and their intended and approved usage can vary by territory. We strive to ensure physicians can use our products as they are intended for the benefit of the patient.

Take a look at the information below to see the intended use of our Magseed® and Magtrace® magnetic markers with the Sentimag® probe in your country or territory.

If you are a customer, this information is available in your IFU (instructions for use) documentation.

Magseed® marker

Europe

Placement: Any soft tissue.
Implantation: Long-term implantation.

USA

Placement: Any soft tissue.
Implantation: Long-term implantation.

Canada

Placement: Any soft tissue.
Implantation: Up to 30 days in advance of surgery.

Hong Kong

Placement: Breast tissue only.
Implantation: Up to 30 days in advance of surgery.

Australia + New Zealand

Placement: Any soft tissue.
Implantation: Long-term implantation.
Further note: The sponsors address label is required on the side of the carton.

Magtrace® lymphatic tracer

Europe

Usage: All sentinel lymph node biopsy applications.
Injection: Up to 7 days in advance of use.

USA

Usage: Mastectomy only.
Injection: No limit on injection timing.

Canada

Usage: All sentinel lymph node biopsy applications.
Injection: Up to 7 days in advance of use.
Further note: Requires use of 5 micron filter.

Hong Kong

Usage: All sentinel lymph node biopsy applications.
Injection: Up to 7 days in advance of use.